9th International Conference on Molecular Biology and Nucleic Acids

Aug 02-03, 2023

|

Madrid, Spain





https://youtu.be/ed-Xo8N3sLI



LexisConferences Conferences is a global leader in producing high-quality conferences, meetings, workshops, and symposia all told major fields of science, technology, and medicine. LexisConferences Conferences Meetings Meetings  Organizes 1000+ Global Events Every Year across the USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contain over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.

LexisConferencesConferences Welcomes all the Directors/Managers & Business Delegates, Founders, Director of Laboratories, Universities, Industries, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Technology Experts, Biomedical Research companies research scholars, industrial professionals, and student delegates from research sectors to be a part of the esteemed Nucleic Acid 2023 Conference and to make the conference an ideal platform for sharing, exchanging and exploring latest findings, clinical experiences, research results, novel strategies, and advancement of emerging technology applications for the innovation and modernization across the globe. As this will be the best amalgamation of academia and research involving every aspect of novel imaging techniques and drug designing. It is open to all types of research methodologies both from academia and industry.

About Conference

Nucleic Acid 2023 aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Nucleic Acid and Molecular Biology. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Nucleic Acid and Molecular Biologya.

Why to attend?

Encounter the target market with members from across the globe, committed to learning about Molecular biology & Nucleic Acid innovation & techniques. This is the best opportunity to outreach the largest gathering of participants from around the world. Conduct presentations, distribute and update knowledge about the current situation of research techniques related to living beings and receive name recognition at this 2-days event. World-eminent speakers, the most recent research, the latest treatment techniques, and the advanced updates in this field are the principal features of this conference. In addition to keynote presentations and a variety of poster presentations along with workshops and interactive sessions and lectures by world-renowned invited speakers. We will be offering special sessions, and hands-on workshops would be interesting to the audience.

 Target Audience

  • Pharmaceutical & Biotechnology Companies

  • Researchers & Innovators, Scientists

  • Doctors and scholars

  • R & D Labs

  • Professors and Students

  • Pharmacists and Medical representatives

  • Noble laureates in Health Care and Medicine

  • Universities and Research Institution

  • Related Associations, Societies, & Professional Bodies

  • Supply Chain and Manufacturing Companies

  • Product Developers

  • Experts Looking for Collaborative Work

  • Bio instruments Professionals

  • Solution Providers

  • Industry directors and Leaders

  • Bio-informatics Professionals

  • Directors of Biotech and Pharma Associations

  • Sales & Marketing Professional

  • Founders and Employees of the related companies

  • Heads, Deans and Professors of Biotechnology and related departments

  • Management/Business leaders and/or agents

  • Writers

  • Opportunities for Conference Attendees

  • Government/non-government community groups or individuals

 

Important Dates

Early Bird Registration: - November 25 2022

Abstract Submission: - November 20 2022

 

Market Analysis

U.S. Molecular Biology Enzymes and kits & reagents market by product, 2021- 2025 ($ billion)

Technological advancements in molecular biology enzymes, kits, and reagents are one of the factors contributing to growth. Manufacturers continuously develop advanced products with an objective to increase their share. These advanced products aim to ease research processes by offering enhanced efficiency and higher precision. For instance, in June 2015, Thermo Fisher Scientific, Inc. (U.S.) launched the new SMART Digest Kit, which was designed for biopharmaceutical and proteomic applications. The kit was designed to generate high-quality data with a significantly reduced sample preparation time compared to traditional in-solution digestion methods.

Increasing investments by pharmaceutical & biotechnology companies in research activities increased the availability of funds for academic & research institutions, and provisions of reimbursement for molecular diagnostics are other significant factors propelling growth.

Genetic information of an individual is highly confidential, hence cannot be shared. Genome sequencing aids in the identification and treatment of various diseases & disorders. Globally, there are no effective tools to secure the genetic information of an individual. Genetic information is accessible to doctors and insurance companies. This information is stored in a cloud database and can be used by researchers across the globe. Thus, lack of high-end technology to store genetic information is likely to restrain growth in the coming years.

Global molecular biology enzymes and kits & reagents market by application, 2016 (%)

The sequencing application segment is estimated to grow at the fastest rate during the forecast period. In the recent years, hospitals in developed or developing countries are implementing sequencing-based medical treatment. Furthermore, sequencing is also being used in cancer diagnosis, therapy, and treatment in collaboration with bioinformatics. In addition, the decreasing cost of sequencing is expected to increase the demand for sequencing during the forecast period.

Epigenetics is used during drug development and discovery process of cancer drugs. In the recent years, many countries across the globe are witnessing growth in the biopharmaceutical and biotechnology industry. For instance, according to the India Brand Equity Foundation, the biopharmaceutical industry in India was worth USD 11 million in 2016 and is estimated to reach USD 11.6 billion by 2017.

Synthetic biology is a new method wherein engineering principles are combined with biology to make new biological products. The growth of the synthetic biology market can be attributed to decreasing cost of DNA sequencing and increasing demand for vaccines, drugs, genetically modified crops, & biofuels.

Molecular Biology Enzymes, Kits and Reagents

The global market for molecular biology enzymes, kits, and reagents, which was anticipated to be worth USD 16600 million in 2022 due to the COVID-19 pandemic and the influence of the Russia-Ukraine War, is expected to increase at a CAGR of 8.4% from 2022 to 2028 to reach USD 26940 million.

In terms of revenue, North America dominated the market for molecular biology enzymes, kits, and reagents in 2017, and it is predicted that it will continue to do so during the assessment period.

This research also discusses the top vendors in each geographical market for molecular biology enzymes, kits, and reagents. Additionally, it describes the key factors influencing the global market for molecular biology enzymes, kits, and reagents as well as current developments in the sector.

Market size (sales, revenue) forecast for the Molecular Biology Enzymes, Kits, and Reagents sector by regions and countries for the period of 2023 to 2027.

The comprehensive data is based on recent developments and historical turning points.

The amount of production for the global market and for each type from 2017 to 2027 is also examined in this section. The volume of production by region from 2017 to 2027 is discussed in this section. The research contains pricing analysis for each kind from 2017 to 2027, each manufacturer from 2017 to 2023, each area from 2017 to 2023, and the global price from 2017 to 2027. The market share of molecular biology enzymes, kits, and reagents as well as distributors, significant suppliers, fluctuating price trends, and the raw materials supply chain are covered in the research.

Synthetic Biology Market

A Global Market Overview is a new market research report from Industry Experts, Inc. The latest analysis suggests that Chassis Organisms is expected to increase at the quickest rate in the upcoming years, while Oligonucleotides is expected to lead the global market for Synthetic Biology products and reach US$9 billion by 2023.

In synthetic biology, the principles of engineering are coupled with the concepts of molecular biology and systems biology to create biological systems and bio-factories with the aim of developing superior biological functions that can address present and future issues. Synthetic biology, according to experts, has the potential to revolutionize how energy is produced, food is produced, industrial processes are optimised, and diseases are identified, avoided, and treated.

Oligonucleotides, Enzymes, Chassis Organism, and others are among the product categories in the market for synthetic biology that were examined in this study (Cloning Technology Kits, Xeno Nucleic Acids etc.). The Synthetic Biology Technologies examined in this research include DNA Sequencing, Biological Components and Integrated Systems, Pathway Engineering, Bioinformatics, Microfluidics, and other technologies. The research also includes a market analysis for synthetic biology applications in the fields of agriculture, biomaterials, industry, medicine, and the environment. Genome engineering is the single most important technology in the global market for synthetic biology, which is expected to grow from US$2.9 billion in demand in 2017 (45% share) to US$9.4 billion by 2023. The market for biological components and integrated systems is anticipated to grow at the quickest rate, or 24.8%, between 2017 and 2023.

The market for synthetic biology is reviewed, analyzed, and projected for the years 2014 to 2023 globally as well as for the regional markets in North America, Europe, Asia-Pacific, and the rest of the world in terms of USD. The regional markets were further examined for 14 independent nations in Asia-Pacific (Japan, China, Australia, and India), Europe (the UK, Germany, France, Italy, and Spain), North America (the United States, Canada, and Mexico), and the rest of the world (Brazil and Israel). The market for synthetic biology in the aforementioned regions is analyzed in the report by key countries, technologies, product types, and end-use applications.

In the paper, 36 main players from North America (27), Europe (6), and Asia-Pacific (31) are profiled, along with 19 prominent worldwide players. The study also lists companies that manufacture semi-synthetic enzymes, sweeteners, and pharmaceutical items in addition to those that offer tools, services, and technology related to synthetic biology. A total of 233 businesses are represented in the global list of firms, including their addresses, phone numbers, and websites.

America dominates with major share and growth in the Synthetic Biology Market

The market for synthetic biology is dominated by the Americas, with Europe, Asia-Pacific, and the rest of the globe following. The American market will reach $7.94 billion by the end of 2023 with a CAGR of 29.9%. The United States is the market's top-performing region, growing at a CAGR of 30.2% overall. The second-largest market is in Europe, which is expected to increase at a CAGR of 29.9% to $6.31 million by 2023. By 2023, the Asia-Pacific market will have grown more quickly—at a CAGR of 33%—and will be worth $5356 million. The demand for synthetic biological products, such as biofuels and other bio-plastics, is rising, which is boosting the synthetic biology market's sales in the Asia-Pacific region.

Xeno-nucleic acids, chassis organisms, oligonucleotide synthesis, cloning technology kits, systemic enzymes, and others are included in the synthetic biology market. In 2017, cloning technology kits accounted for $1.72 billion of the market's total value. The data for the report's tools segment will help you understand how the cloning technology market leads the industry and is predicted to develop at a CAGR of 29.70% to reach $8.18 billion in value by 2023. While Xeno-Nucleic Acids are predicted to expand at a CAGR of 34.1% from 2018 to 2023 as a result of an increase in medical applications as a disease-fighting tool.

Selected Tool and Technology Analysis done Report:

The synthetic biology market is divided into categories based on technology including DNA synthesis and sequencing, computational modelling, bioinformatics technology, microfluidics chip, nano technology chip, route engineering, and others. The market for bioinformatics technology is expected to develop at a CAGR of 27.5% to reach $4.5 billion in value by 2023. The market for pathway genetic engineering is anticipated to develop at a CAGR of 39.2% from 2018 to 2023, while the industry for computational modelling is predicted to grow at a CAGR of just 22.2%.

Market Growth Factors Excerpts

In the medical field, synthetic biology technology is being used in a variety of ways for the production of cutting-edge medications and therapies as well as the regeneration of artificial tissue.

The necessity for developing alternative fuels is important because of the growing scarcity of fuel and the harmful effects that excessive fuel consumption has on the environment. Renewable energy sources and biodegradable polymers are being developed thanks to synthetic biology. The synthetic biology market has been pushed by the desire for alternative fuel to lessen reliance on natural fuel.

The development of genetic and molecular biology is now being fueled by notable technologies like improved polymerase chain reaction (PCR) and next generation sequencing (NGS).

 

Global Genetics & Molecular Biology Universities:

America:

  • Michigan State University, USA

  • University of California, USA

  • Arizona State University, USA

  • New York University, USA

  • Pennsylvania State University, USA

  • University of Illinois at Urbana-Champaign, USA

  • University of Michigan, USA

  • University of Texas at Austin, USA

  • University of Wisconsin - Madison, USA

  • University of Toronto, USA

  • Johns Hopkins University, USA

  • University of Oxford, USA

  • University of Washington, USA

  • Stanford University, USA

  • University of Cambridge, USA

  • Massachusetts Institute of Technology, USA

  • Harvard University, USA

  • University of Toronto, Canada

  • McGill University, Canada

  • University of British Columbia, Canada

 Europe:

  • University of Cambridge, UK

  • University of Oxford, UK

  • University College London, UK

  • Imperial College London, UK

  • University of Edinburgh, UK

  • King's College London, UK

  • Queen Mary University of London, UK

  • University of Manchester, UK

  • University of Bristol, UK

  • University of Glasgow, UK

  • Cardiff University, UK

  • University of Dundee, UK

  • University of Nottingham, UK

  • University of Munich, Germany

  • Heidelberg University, Germany

  • Technical University of Munich, Germany

  • Charite - Medical University of Berlin, Germany

  • University of Bonn, Germany

  • University of Cologne, Germany

  • University of Freiburg, Germany

  • Free University of Berlin, Germany

  • Humboldt University of Berlin, Germany

  • Eberhard Karls University, Germany

  • Moscow State University, Russia

 Asia:

  • University of Tokyo, Japan

  • Osaka University, Japan

  • Hokkaido University, Japan

  • Kyoto University, Japan

  • Nagasaki University, Japan

  • University of Queensland, Australia

  • University of Melbourne, Australia

  • University of Sydney, Australia

  • University of New South Wales, Australia

  • Monash University, Australia

 Middle East:

  • Cairo University, Egypt

  • Ain Shams University, Egypt

  • Zagazig University, Egypt

  • Kuwait University, Kuwait

  • Al Azhar University, Egypt

  • Alexandria University, Egypt

  • Mansoura University, Egypt

  • Menoufia University, Egypt

  • Universal Empire Institute of Medical Sciences, UAE

  • Shaheed Zulfikar Ali Bhutto Institute of Science and Technology, UAE

Global Genetics & Molecular Biology Research Centers & Associations:

America:

  • American College Of Molecular Biology Pathologists, USA

  • American Association for the Advancement of Science, USA

  • American Chemical Society, USA

  • Botanical Society of America, USA

  • California Academy of Sciences, USA

  • Society for Science and the Public, USA

  • United States National Academies, USA

  • Academy of Medicine, Engineering and Science of Texas, USA

  • American Association for the Advancement of  Science, USA

  • American Urological and Lichenological Society, USA

  • American Fern Society, USA

  • American Institute for Medical and Biological Engineering, USA

  • American Institute of Biological Sciences, USA

  • American Society for Biochemistry and Molecular Biology, USA

  • Arabidopsis Biological Resource Center, USA

  • Association for Laboratory Automation, USA

  • Biological Society of Washington, USA

  • California Academy of Sciences, USA

  • Center for Science in the Public Interest, USA

  • Federation of American Societies for Experimental Biology, USA

  • National Academy of Sciences, USA

Europe:

  • Genetics Society, UK

  • Anatomical Society, UK

  • Astrobiology Society of Britain, UK

Program Overview